Key result
This review summarizes current knowledge on the etiology, classification, diagnosis, management, therapy, and prognosis of pericardial effusion in clinical practice.
This review summarizes current knowledge on the etiology, diagnosis, and management of pericardial effusion in clinical practice.
Prognostic data on pericardial effusion remain limited; leaves open need for validated risk models before guiding practice.
A pericardial effusion (PE) is a relatively common finding in clinical practice. It may be either isolated or associated with pericarditis with or without an underlying disease. The aetiology is varied and may be either infectious (especially tuberculosis as the most common cause in developing countries) or non-infectious (cancer, systemic inflammatory diseases). The management is essentially guided by the hemodynamic effect (presence or absence of cardiac tamponade), the presence of concomitant pericarditis or underlying disease, and its size and duration. The present paper reviews the current knowledge on the aetiology, classification, diagnosis, management, therapy, and prognosis of PE in clinical practice.
No takes yet. Share an insight, caveat, or question.
Imazio et al. (2017) conducted a review in Pericardial effusion. This review summarizes current knowledge on the etiology, classification, diagnosis, management, therapy, and prognosis of pericardial effusion in clinical practice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: